Is CODEXIS, INC. (CDXS) Halal?

NASDAQ Healthcare United States $144M
✗ NOT HALAL
Confidence: 90/100
CODEXIS, INC. (CDXS) is Not Halal under AAOIFI Standard 21. The company's debt ratio of 53.9% exceeds the 30% threshold, indicating excessive interest-bearing debt relative to market capitalization. CODEXIS, INC. operates in the Healthcare sector.

Shariah Screening — 5 Standards

Based on financial data from December 2025

Standard Debt Ratio Cash Ratio Receivables Income Status
AAOIFI 53.9%
/ 30%
66.1%
/ 30%
17.0%
/ 30%
6.18%
/ 5%
✗ NOT HALAL
DJIM 53.9%
/ 33%
66.1%
/ 33%
17.0%
/ 33%
6.18%
/ 5%
✗ NOT HALAL
MSCI 40.2%
/ 33%
49.3%
/ 33%
12.7%
/ 33%
6.18%
/ 5%
✗ NOT HALAL
S&P 53.9%
/ 33%
66.1%
/ 33%
17.0%
/ 33%
6.18%
/ 5%
✗ NOT HALAL
FTSE 40.2%
/ 33%
49.3%
/ 33%
12.7%
/ 50%
6.18%
/ 5%
✗ NOT HALAL

Financial Highlights

EPS
$-0.50
P/B Ratio
2.8
EV/EBITDA
-4.2
EV: $139M
Revenue
$70M
Growth: 81.3%
Beta
2.5
High volatility
Current Ratio
3.8

Profitability

Gross Margin 12.4%
Operating Margin 35.9%
Net Margin -62.5%
Return on Equity (ROE) -74.9%
Return on Assets (ROA) -16.1%

Cash Flow & Balance Sheet

Operating Cash Flow-$19M
Free Cash Flow-$24M
Total Debt$73M
Debt-to-Equity144.9
Current Ratio3.8
Total Assets$148M

Price & Trading

Last Close$1.66
50-Day MA$1.37
200-Day MA$2.10
Avg Volume2.2M
Beta2.5
52-Week Range
$0.96
$3.87

About CODEXIS, INC. (CDXS)

CEO
Dr. Alison Moore Ph.D.
Employees
146
Sector
Healthcare
Industry
Biotechnology
Country
United States
Exchange
NASDAQ
Market Cap
$144M
Currency
USD

Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a license agreement with Aldevron LLC and Pfizer Inc. The company was incorporated in 2002 and is headquartered in Redwood City, California.

Related Halal Stocks in Healthcare

Frequently Asked Questions

Is CODEXIS, INC. (CDXS) halal to invest in?

Based on our screening using AAOIFI Standard 21 (the strictest methodology), CODEXIS, INC. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.

What is CODEXIS, INC.'s debt ratio?

CODEXIS, INC.'s debt ratio is 53.9% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 40.2%.

What are CODEXIS, INC.'s key financial metrics?

CODEXIS, INC. has a market capitalization of $144M, and revenue of $70M. The company maintains a gross margin of 12.4% and a net margin of -62.5%. Return on equity stands at -74.9%.

How often is the screening data updated?

Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.

Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.